Sequana Medical Announces US FDA Approval of alfapump® for the Treatment of Recurrent or Refractory Ascites due to Liver Cirrhosisalfapump® is ...

There are limited effective treatment options, resulting in poor clinical ... treatment of recurrent or refractory ascites due to liver cirrhosis in December 2024, following the grant of FDA ...

There are limited effective treatment options, resulting in poor clinical outcomes ... The Company received US FDA approval for the alfapump System for the treatment of recurrent or refractory ascites ...

Liver cirrhosis is a late-stage liver disease characterized ... visible spider-like blood vessels, and palm redness. Treatment focuses on addressing underlying causes, such as alcohol dependency ...

Liver elastography confirms liver fibrosis (stiffness) and helps providers reach a diagnosis to suggest treatment. Learn ...

Causes of compensated cirrhosis may include nonalcoholic fatty liver disease (NAFLD), alcohol-related liver disease, and chronic hepatitis B and C. Treatment for the condition will depend on the ...

Depending on the severity of your condition, you may need further treatment. For example, fatty liver disease can lead to cirrhosis. Cirrhosis can cause serious health issues that require ...

The only thing that can cure cirrhosis is a liver transplant. Treatment aims to manage symptoms. Along with quitting drinking, options include: seeking medical help for alcohol dependency low ...

The global cirrhosis management market is projected to grow from US$ 725 million in 2023 to US$ 1,052.3 million by 2033, with ...

While the treatment options for this aggressive type of cancer ... which are linked to liver cirrhosis and other serious health ... Mechanism of Action of the Hepatitis B and D Virus Cell Entry ...

It also explores the treatment options and how to stay well if diagnosed with the disease ... Over time, the mounting fibrosis can lead to a significant loss of liver function, known as cirrhosis. If ...